These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 24064317

  • 1. Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: is re-excision necessary?
    Sadek BT, Shenouda MN, Abi Raad RF, Niemierko A, Keruakous AR, Goldberg SI, Taghian AG.
    Int J Radiat Oncol Biol Phys; 2013 Nov 15; 87(4):726-30. PubMed ID: 24064317
    [Abstract] [Full Text] [Related]

  • 2. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S, Kestin LL, Goldstein NS, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):365-71. PubMed ID: 16965988
    [Abstract] [Full Text] [Related]

  • 3. Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis.
    Ben-David MA, Kleer CG, Paramagul C, Griffith KA, Pierce LJ.
    Cancer; 2006 Jan 01; 106(1):28-34. PubMed ID: 16329136
    [Abstract] [Full Text] [Related]

  • 4. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1337-47. PubMed ID: 15817335
    [Abstract] [Full Text] [Related]

  • 5. Breast conservation therapy for invasive lobular carcinoma: the impact of lobular carcinoma in situ in the surgical specimen on local recurrence and axillary node status.
    Stolier AJ, Barre G, Bolton JS, Fuhrman GM, Looney S.
    Am Surg; 2004 Sep 01; 70(9):818-21. PubMed ID: 15481302
    [Abstract] [Full Text] [Related]

  • 6. The safety of multiple re-excisions after lumpectomy for breast cancer.
    Coopey S, Smith BL, Hanson S, Buckley J, Hughes KS, Gadd M, Specht MC.
    Ann Surg Oncol; 2011 Dec 01; 18(13):3797-801. PubMed ID: 21630123
    [Abstract] [Full Text] [Related]

  • 7. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ.
    Fisher ER, Costantino J, Fisher B, Palekar AS, Paik SM, Suarez CM, Wolmark N.
    Cancer; 1996 Oct 01; 78(7):1403-16. PubMed ID: 8839545
    [Abstract] [Full Text] [Related]

  • 8. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
    Aziz D, Rawlinson E, Narod SA, Sun P, Lickley HL, McCready DR, Holloway CM.
    Breast J; 2006 Oct 01; 12(4):331-7. PubMed ID: 16848842
    [Abstract] [Full Text] [Related]

  • 9. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
    Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, Sigurdson E, Boraas M, Goldstein L.
    Int J Radiat Oncol Biol Phys; 1999 Jul 15; 44(5):1005-15. PubMed ID: 10421533
    [Abstract] [Full Text] [Related]

  • 10. Does Non-Classic Lobular Carcinoma In Situ at the Lumpectomy Margin Increase Local Recurrence?
    Beck AC, Bayard S, Plitas G, Sevilimedu V, Kuba MG, Garcia P, Morrow M, Tadros AB.
    Ann Surg Oncol; 2023 Oct 15; 30(10):6061-6069. PubMed ID: 37493892
    [Abstract] [Full Text] [Related]

  • 11. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results].
    Fodor J, Sulyok Z, Polgár C, Major T, Tóth J, Németh G.
    Magy Seb; 2001 Aug 15; 54(4):209-14. PubMed ID: 11550486
    [Abstract] [Full Text] [Related]

  • 12. Negative margin status improves local control in conservatively managed breast cancer patients.
    Obedian E, Haffty BG.
    Cancer J Sci Am; 2000 Aug 15; 6(1):28-33. PubMed ID: 10696736
    [Abstract] [Full Text] [Related]

  • 13. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT, Jones SO, Kader HA, Wai ES, Speers CH, Alexander AS, Olivotto IA.
    Int J Radiat Oncol Biol Phys; 2009 Feb 01; 73(2):357-64. PubMed ID: 18676091
    [Abstract] [Full Text] [Related]

  • 14. Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ?
    Cutuli B, de Lafontan B, Quetin P, Mery E.
    Eur J Cancer; 2005 Feb 01; 41(3):380-5. PubMed ID: 15691636
    [Abstract] [Full Text] [Related]

  • 15. Is a higher boost dose of radiation necessary after breast-conserving therapy for patients with breast cancer with final close or positive margins?
    Sadek BT, Homayounfar G, Abi Raad RF, Niemierko A, Shenouda MN, Keruakous AR, Specht MC, Taghian AG.
    Breast Cancer Res Treat; 2015 Nov 01; 154(1):71-9. PubMed ID: 26420403
    [Abstract] [Full Text] [Related]

  • 16. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
    Valdes EK, Boolbol SK, Cohen JM, Feldman SM.
    Ann Surg Oncol; 2007 Mar 01; 14(3):1045-50. PubMed ID: 17206481
    [Abstract] [Full Text] [Related]

  • 17. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    Fowble B, Hanlon AL, Patchefsky A, Freedman G, Hoffman JP, Sigurdson ER, Goldstein LJ.
    Int J Radiat Oncol Biol Phys; 1998 Aug 01; 42(1):105-15. PubMed ID: 9747827
    [Abstract] [Full Text] [Related]

  • 18. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
    Monteau A, Sigal-Zafrani B, Kirova YM, Fourchotte V, Bollet MA, Vincent-Salomon A, Asselain B, Salmon RJ, Fourquet A.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1021-8. PubMed ID: 19386441
    [Abstract] [Full Text] [Related]

  • 19. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.
    Sasson AR, Fowble B, Hanlon AL, Torosian MH, Freedman G, Boraas M, Sigurdson ER, Hoffman JP, Eisenberg BL, Patchefsky A.
    Cancer; 2001 May 15; 91(10):1862-9. PubMed ID: 11346867
    [Abstract] [Full Text] [Related]

  • 20. Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Russo AL, Arvold ND, Niemierko A, Wong N, Wong JS, Bellon JR, Punglia RS, Golshan M, Troyan SL, Brock JE, Harris JR.
    Breast Cancer Res Treat; 2013 Jul 15; 140(2):353-61. PubMed ID: 23836011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.